1. 106Gender disparities of distribution of epicardial adipose tissue and its impact on coronary artery disease. (28th August 2018) Authors: Maimaituxun, G; Shimabukuro, M; Fukuda, D; Yagi, S; Hirata, Y; Iwase, T; Matsuura, T; Ise, T; Kusunose, K; Tobiume, T; Yamaguchi, K; Yamada, H; Soeki, T; Wakatsuki, T; Sata, M Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 112PA retrospective analysis of the association between perioperative, post adjuvant carcinoembryonic antigen level and prognosis in stage III colorectal cancer. (24th November 2019) Authors: Kozuki, R; Shinozaki, E; Osumi, H; Wakatuki, T; Suenaga, M; Ogura, M; Suzuki, T; Nakayama, I; Takahari, D; Chin, K; Nagasaki, T; Konishi, T; Nagayama, S; Fukunaga, Y; Ueno, M; Yamaguchi, K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 134PA retrospective analysis of the association between perioperative carcinoembryonic antigen level and prognosis in stage III colorectal cancer. (25th November 2018) Authors: Kozuki, R; Shinozaki, E; Osumi, H; Wakatsuki, T; Suenaga, M; Ichimura, T; Ogura, M; Suzuki, T; Ota, Y; Nakayama, I; Takahari, D; Chin, K; Nagasaki, T; Akiyoshi, T; Konishi, T; Fujimoto, Y; Nagayama, S; Fukunaga, Y; Ueno, M; Yamaguchi, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 198TiPSPOTLIGHT: Comparison of zolbetuximab or placebo + mFOLFOX6 as first-line treatment in patients with claudin18.2+/HER2– locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma (GEJ): A randomized phase III study. (24th November 2019) Authors: Yamaguchi, K; Shitara, K; Al-Batran, S-E; Bang, Y-J; Catenacci, D; Enzinger, P; Ilson, D; Kim, S; Lordick, F; Shah, M; Van Cutsem, E; Xu, R-H; Arozullah, A; Wook Park, J; Ajani, J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 19PIs sarcopenia associated with increased toxicity of neoadjuvant/adjuvant chemotherapy for breast cancer?. (25th November 2018) Authors: Ueno, A; Yamaguchi, K; Sudo, M; Imai, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 208TiPA randomized, phase II, multicenter, open-label study of trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing gastric cancer. (25th November 2018) Authors: Shitara, K; Bang, Y-J; Sakai, D; Yasui, H; Kawaguchi, Y; Sugihara, M; Saito, K; Dalal, R; Yamaguchi, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 471PA phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study. (23rd October 2018) Authors: Suenaga, M; Wakatsuki, T; Ogura, M; Ichimura, T; Shinozaki, E; Nakayama, I; Osumi, H; Ota, Y; Chin, K; Mashima, T; Seimiya, H; Takahari, D; Yamaguchi, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 481PPhase II study of cetuximab rechallenge in patients with ras wild-type metastatic colorectal cancer: E-rechallenge trial. (23rd October 2018) Authors: Osawa, H; Shinozaki, E; Nakamura, M; Ohhara, Y; Shindo, Y; Shiozawa, M; Uetake, H; Matsumoto, H; Ureshino, N; Satake, H; Kobayashi, T; Suto, T; Kitano, S; Ohashi, Y; Uemura, K; Yamaguchi, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 508Pp16 and PD-L1 expression in locoregional squamous cell carcinoma of the anal canal: A single center retrospective analysis in Japan. (23rd October 2018) Authors: Takahashi, R; Wakatsuki, T; Yamamoto, N; Taguchi, S; Shinozaki, E; Osumi, H; Ogura, M; Ichimura, T; Takahari, D; Suenaga, M; Chin, K; Oguchi, M; Ueno, M; Yamaguchi, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 563PUpdated results of phase I study of trastuzumab deruxtecan (DS-8201a) in HER2-expressing advanced colorectal cancer. (23rd October 2018) Authors: Yoshino, T; Iwata, H; Tamura, K; Takahashi, S; Redfern, C; Modi, S; Doi, T; Kawakami, H; Taniguchi, H; Takashima, A; Yamaguchi, K; Fisher, J; Li, B; Saito, K; Fujisaki, Y; Sugihara, M; Tsurutani, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗